ASSESSMENT OF LYMPHONOD IDENTIFICATION RATE PREVIOUSLY MARKED WITH 4% CARBON SUSPENSION IN PATIENTS WITH BREAST CANCER SUBJECT TO NEOADJUVANT CHEMOTHERAPY
BUDEL, L. R. (UFPR), BUDEL, VM M. (UFPR), SPAUTZ, C.C (UFPR), GASPERIN, P. (UFPR), LOUVEIRA, M.H. (UFPR), CAVALCANTI, T.C.S. (UFPR)